UBS Group’s Addentax Group ATXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209 Sell
69
-1,568
-96% -$7.83K ﹤0.01% 9992
2026
Q1
$9.02K Buy
1,637
+1,558
+1,972% +$8.13K ﹤0.01% 8468
2025
Q4
$465 Buy
79
+61
+339% +$549 ﹤0.01% 9947
2025
Q3
$275 Buy
+18
New +$167 ﹤0.01% 9765
2023
Q4
Sell
-120
Closed -$2.44K 9290
2023
Q3
$2.44K Buy
120
+69
+135% +$2.89K ﹤0.01% 7704
2023
Q2
$5.06K Buy
+51
New +$6.17K ﹤0.01% 7477
2023
Q1
Sell
-47
Closed -$7.54K 9588
2022
Q4
$7.54K Sell
47
-82
-64% -$23.1K ﹤0.01% 8887
2022
Q3
$55K Buy
+129
New +$684K ﹤0.01% 6252

Other funds holding ATXG

UBS Group's ATXG Position: Q2 2026 in Review

UBS Group reduced its Addentax Group (ATXG) stake by 96% in Q2 2026, selling an estimated $7.83K and leaving 69 shares worth $209. The position accounts for ﹤0.01% of the portfolio, ranked #9992.

UBS Group first reported a position in ATXG in Q3 2022 and has held it in 8 quarters since. The position peaked at $55K in Q3 2022. 2 funds tracked by Wall St. Rank hold ATXG as of Q2 2026.

  • UBS Group held 69 shares of Addentax Group worth $209 as of Q2 2026.
  • UBS Group sold 1,568 Addentax Group shares in Q2 2026, an estimated $7.83K.
  • Addentax Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9992 holding.
  • UBS Group first reported a position in Addentax Group in Q3 2022 and has held it in 8 quarters since.
  • UBS Group's Addentax Group position peaked at $55K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Addentax Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.